Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Coya Therapeutics

Tracked across 3 events · 60 articles · First seen Feb 11, 2025 · Last active Jun 02, 2026

Sentiment
-27
Attention
6
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -90
Business
Impact: Coya Therapeutics is facing multiple class action lawsuits for allegedly misleading investors about the safety of its Duchenne muscular dystrophy gene therapy, Delandistrogene moxeparvovec, after several patient deaths due to acute liver failure. This has led to significant stock price declines and regulatory scrutiny.
Jun 27, 2025 · 44 articles
2 10
Business
Impact: Coya Therapeutics is a publicly traded company presenting at the conference, seeking to engage with investors and highlight its advancements.
Apr 02, 2026 · 7 articles
2 0
Business
Impact: Dieter Weinand currently serves on the board of Coya Therapeutics, and will reduce his board seats to focus on his role at Evotec.
Apr 07, 2026 · 9 articles
ERGEN INTELLIGENCE
Track Coya Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.